advertisement

cancer

common drug used to treat prostate cancer may raise risk of brain tumours: study

researchers suggest 'careful' use of hormone therapy drug cyproterone because of link to slow-growing tumour.
dave yasvinski
feb 7 2022

imagine waiting more than a year to find out if you have cancer

'cancer was no longer important,' says mélodie cyr, who had surgery for a nodule on her thyroid. 'they were putting all the emphasis on covid, however, cancer was still happening.'
maija kappler
feb 7 2022

'stem cell clinics are an area of risk': a conversation with peter zandstra, recently named to the order of canada

the canadian scientist's latest research is focused on figuring out how stem cells from umbilical cord blood can replace stem cell transplants.
emma jones
jan 27 2022

gist: what it feels like

maureen went from feeling completely healthy to hearing a doctor tell her that she had gastrointestinal stromal tumours, a rare cancer that affects 1 in 100,000 people.
emma jones
jan 25 2022

how hpv turned into cervical cancer years later for a b.c. woman

it has been five years since corinne schelle was diagnosed with cervical cancer — a disease that now can be prevented with a vaccine.
karen hawthorne
jan 24 2022

hormone therapy gives men at high risk for prostate cancer a better chance of survival

hormone therapy prevented one trial participant from developing metastatic disease 10 years after treatment.
chris arnold
jan 21 2022

scotland's 'significant leap forward’: two breast cancer drugs approved; england urged to follow suit

canada has already approved the treatments which can slow progression of her2-positive breast cancer.
emma jones
jan 19 2022

chris evert on ovarian cancer: 'don't try to be a crusader and think this will pass'

evert's sister jeanne evert dubin was diagnosed with late stage ovarian cancer and died in february 2020.
maija kappler
jan 18 2022
powered by
canadian society for exercise physiology
powered by
the leukemia & lymphoma society of canada (llsc)

common drug used to treat prostate cancer may raise risk of brain tumours: study

researchers suggest 'careful' use of hormone therapy drug cyproterone because of link to slow-growing tumour.
dave yasvinski
feb 7 2022

imagine waiting more than a year to find out if you have cancer

'cancer was no longer important,' says mélodie cyr, who had surgery for a nodule on her thyroid. 'they were putting all the emphasis on covid, however, cancer was still happening.'
maija kappler
feb 7 2022

'stem cell clinics are an area of risk': a conversation with peter zandstra, recently named to the order of canada

the canadian scientist's latest research is focused on figuring out how stem cells from umbilical cord blood can replace stem cell transplants.
emma jones
jan 27 2022

gist: what it feels like

maureen went from feeling completely healthy to hearing a doctor tell her that she had gastrointestinal stromal tumours, a rare cancer that affects 1 in 100,000 people.
emma jones
jan 25 2022

how hpv turned into cervical cancer years later for a b.c. woman

it has been five years since corinne schelle was diagnosed with cervical cancer — a disease that now can be prevented with a vaccine.
karen hawthorne
jan 24 2022

hormone therapy gives men at high risk for prostate cancer a better chance of survival

hormone therapy prevented one trial participant from developing metastatic disease 10 years after treatment.
chris arnold
jan 21 2022

scotland's 'significant leap forward’: two breast cancer drugs approved; england urged to follow suit

canada has already approved the treatments which can slow progression of her2-positive breast cancer.
emma jones
jan 19 2022

chris evert on ovarian cancer: 'don't try to be a crusader and think this will pass'

evert's sister jeanne evert dubin was diagnosed with late stage ovarian cancer and died in february 2020.
maija kappler
jan 18 2022
powered by
canadian society for exercise physiology

advertisement

advertisement